References
- Weilbaecher KN, Guise TA, McCauley LK. Cancer to bone: a fatal attraction. Nat Rev Cancer 2011; 11:411 - 25; http://dx.doi.org/10.1038/nrc3055; PMID: 21593787
- Kudo-Saito C, Shirako H, Takeuchi T, Kawakami Y. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 2009; 15:195 - 206; http://dx.doi.org/10.1016/j.ccr.2009.01.023; PMID: 19249678
- Kudo-Saito C, Shirako H, Ohike M, Tsukamoto N, Kawakami Y. CCL2 is critical for immunosuppression to promote cancer metastasis. Clin Exp Metastasis 2013; 30:393 - 405; http://dx.doi.org/10.1007/s10585-012-9545-6; PMID: 23143679
- Kudo-Saito C, Fuwa T, Murakami K, Kawakami Y. Targeting FSTL1 prevents tumor bone metastasis and consequent immune dysfunction. Cancer Res 2013; Forthcoming http://dx.doi.org/10.1158/0008-5472.CAN-13-1364; PMID: 23966294
- Kong D, Li Y, Wang Z, Sarkar FH. Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?. Cancers (Basel) 2011; 3:716 - 29; http://dx.doi.org/10.3390/cancers30100716; PMID: 21643534
- Adams D, Larman B, Oxburgh L. Developmental expression of mouse Follistatin-like 1 (Fstl1): Dynamic regulation during organogenesis of the kidney and lung. Gene Expr Patterns 2007; 7:491 - 500; http://dx.doi.org/10.1016/j.modgep.2006.10.009; PMID: 17129766
- Li D, Wang Y, Xu N, Wei Q, Wu M, Li X, Zheng P, Sun S, Jin Y, Zhang G, et al. Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis. Arthritis Res Ther 2011; 13:R17; http://dx.doi.org/10.1186/ar3241; PMID: 21303509
- Hambrock HO, Kaufmann B, Müller S, Hanisch FG, Nose K, Paulsson M, Maurer P, Hartmann U. Structural characterization of TSC-36/Flik: analysis of two charge isoforms. J Biol Chem 2004; 279:11727 - 35; http://dx.doi.org/10.1074/jbc.M309318200; PMID: 14701841